Show simple item record

dc.contributor.authorRiese, Peggy
dc.contributor.authorTrittel, Stephanie
dc.contributor.authorSchulze, Kai
dc.contributor.authorGuzmán, Carlos A
dc.date.accessioned2015-10-14T13:02:28Zen
dc.date.available2015-10-14T13:02:28Zen
dc.date.issued2015-09en
dc.identifier.citationRodents as pre-clinical models for predicting vaccine performance in humans. 2015, 14 (9):1213-25 Expert Rev Vaccinesen
dc.identifier.issn1744-8395en
dc.identifier.pmid26268433en
dc.identifier.urihttp://hdl.handle.net/10033/579626en
dc.description.abstractVaccines represent a key building block for establishing a successful and sustainable control strategy against infectious diseases. Vaccine development often depends on the availability of correlates for protection and reliable animal models for the screening, selection and prioritization of potential vaccine candidates. This is performed according to their immunogenicity, efficacy and safety profiles in pre-clinical studies, which are also critical for identification of candidate antigens, selection of an optimal delivery system and design of appropriate vaccine formulations. Thus, pre-clinical studies in animal models are a prerequisite for addressing crucial issues and generating a solid pre-clinical package for the approval of clinical trials. This review addresses the strengths, limitations and perspectives of rodents as a vaccine development and pre-clinical validation tool.
dc.language.isoenen
dc.titleRodents as pre-clinical models for predicting vaccine performance in humans.en
dc.typeArticleen
dc.identifier.journalExpert review of vaccinesen
refterms.dateFOA2016-09-01T00:00:00Z
html.description.abstractVaccines represent a key building block for establishing a successful and sustainable control strategy against infectious diseases. Vaccine development often depends on the availability of correlates for protection and reliable animal models for the screening, selection and prioritization of potential vaccine candidates. This is performed according to their immunogenicity, efficacy and safety profiles in pre-clinical studies, which are also critical for identification of candidate antigens, selection of an optimal delivery system and design of appropriate vaccine formulations. Thus, pre-clinical studies in animal models are a prerequisite for addressing crucial issues and generating a solid pre-clinical package for the approval of clinical trials. This review addresses the strengths, limitations and perspectives of rodents as a vaccine development and pre-clinical validation tool.


Files in this item

Thumbnail
Name:
Riese et al_final.pdf
Size:
345.8Kb
Format:
PDF
Description:
original manuscript
Thumbnail
Name:
Riese et al resubmitted Key ...
Size:
59.32Kb
Format:
PDF
Description:
key issues
Thumbnail
Name:
Riese et. al resubmitted Table ...
Size:
88.98Kb
Format:
Microsoft PowerPoint 2007
Description:
Tables and Boxes

This item appears in the following Collection(s)

Show simple item record